Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Angle Plc ADR (ANPCY)

Angle Plc ADR (ANPCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Angle PLC Announces Publication Demonstrates CTC Profiling Potential

PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER

ANPCY : 0.7362 (-35.98%)
AGL : 2.70 (+1.12%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)
Angle PLC Announces Result of 2022 Annual General Meeting

GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP

ANPCY : 0.7362 (-35.98%)
AGL.LN : 8.010 (+0.12%)
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP

ANPCY : 0.7362 (-35.98%)
AGL.LN : 8.010 (+0.12%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)
Angle PLC Announces Secured Contract From Pharma Services Customer

Additional contract for a new clinical trial

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)
Angle PLC Announces Predicting Immunotherapy Response in SCLC

PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)
Angle PLC Announces Potential Role of Invasive Cellular Protrusions

Prostate cancer cells may use invasive cellular protrusions to aid entry into the blood stream, a potential target in the metastatic process for novel therapy development

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)
Angle PLC Announces Partnership with Major United States Urology Group

PARTNERSHIP ESTABLISHED WITH A MAJOR UNITED STATES UROLOGY GROUP TO CONDUCT CLINICAL STUDIES IN PROSTATE CANCER AND AS A POTENTIAL ROUTE TO MARKET

AGL : 2.70 (+1.12%)
ANPCY : 0.7362 (-35.98%)

Barchart Exclusives

Should You Buy Meta Platforms Stock After Earnings?
Despite crushing broader market returns in the past two years, Meta Platforms stock still trades at a reasonable valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar